tiprankstipranks
Evotec initiated with a Buy at H.C. Wainwright
The Fly

Evotec initiated with a Buy at H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao initiated coverage of Evotec with a Buy rating and $12 price target. The company has a platform to drive the discovery and development of novel drugs, Tsao tells investors in a research note. He believes Evotec has established a unique platform that can help clients and partners identify and develop new drugs.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on EVO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles